
    
      To explore the change of glycemic control (HbA1c or FPG) before and after 24 weeks of
      Sitagliptin treatment in Type 2 Diabetic patients who have started Sitagliptin as add on
      therapy during the index period and received Sitagliptin continuously* for at least 24 weeks.
    
  